# Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions

> **NCT07391982** · NA · RECRUITING · sponsor: **The Netherlands Cancer Institute** · enrollment: 54 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)

## Interventions

- **RADIATION:** uniform dose radiotherapy
- **RADIATION:** De-escalated dose radiotherapy

## Key facts

- **NCT ID:** NCT07391982
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-17
- **Primary completion:** 2027-02
- **Final completion:** 2028-12
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391982, "Dose De-escalation in Prostate Radiotherapy Using an MR-Linac in Two Fractions". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07391982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*